TY - JOUR
T1 - Spinal administration of selective opioid antagonists in amphibians
T2 - Evidence for an opioid unireceptor
AU - Stevens, Craig W.
AU - Newman, Leslie C.
PY - 1999/1/29
Y1 - 1999/1/29
N2 - In mammals, opioids act by interactions with three distinct types of receptors: μ, δ, or κ opioid receptors. Using a novel assay of antinociception in the Northern grass frog, Rana pipiens, previous work demonstrated that selective μ, δ, or κ opioids produced a potent antinociception when administered by the spinal route. The relative potency of this effect was highly correlated to that found in mammals. Present studies employing selective opioid antagonists, β-FNA, NTI, or nor-BNI demonstrated that, in general, these antagonists were not selective in the amphibian model. These data have implications for the functional evolution of opioid receptors in vertebrates and suggest that the tested μ, δ, and κ opioids mediate antinociception via a single type of opioid receptor in amphibians, termed the unireceptor.
AB - In mammals, opioids act by interactions with three distinct types of receptors: μ, δ, or κ opioid receptors. Using a novel assay of antinociception in the Northern grass frog, Rana pipiens, previous work demonstrated that selective μ, δ, or κ opioids produced a potent antinociception when administered by the spinal route. The relative potency of this effect was highly correlated to that found in mammals. Present studies employing selective opioid antagonists, β-FNA, NTI, or nor-BNI demonstrated that, in general, these antagonists were not selective in the amphibian model. These data have implications for the functional evolution of opioid receptors in vertebrates and suggest that the tested μ, δ, and κ opioids mediate antinociception via a single type of opioid receptor in amphibians, termed the unireceptor.
KW - Amphibian
KW - Morphine
KW - Opioid antinociception
KW - Opioid receptor
KW - Unireceptor
UR - http://www.scopus.com/inward/record.url?scp=0033613883&partnerID=8YFLogxK
U2 - 10.1016/S0024-3205(99)00013-2
DO - 10.1016/S0024-3205(99)00013-2
M3 - Article
C2 - 10096442
AN - SCOPUS:0033613883
SN - 0024-3205
VL - 64
SP - PL125-PL130
JO - Life Sciences
JF - Life Sciences
IS - 10
ER -